Home
>
National Drug Code (NDC)
>
AMPHOTEC
AMPHOTEC - 66435-302-01 - (Amphotericin B)
Drug Information of AMPHOTEC
| Product NDC: | 66435-302 |
| Proprietary Name: | AMPHOTEC |
| Non Proprietary Name: | Amphotericin B |
| Active Ingredient(s): | 100 mg/100mg & nbsp; Amphotericin B |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, LIPID COMPLEX |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AMPHOTEC
| Product NDC: | 66435-302 |
| Labeler Name: | Kadmon Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050729 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050520 |
Package Information of AMPHOTEC
| Package NDC: | 66435-302-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (66435-302-01) > 100 mg in 1 VIAL, SINGLE-USE |
NDC Information of AMPHOTEC
| NDC Code | 66435-302-01 |
| Proprietary Name | AMPHOTEC |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (66435-302-01) > 100 mg in 1 VIAL, SINGLE-USE |
| Product NDC | 66435-302 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Amphotericin B |
| Dosage Form Name | INJECTION, LIPID COMPLEX |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050520 |
| Marketing Category Name | NDA |
| Labeler Name | Kadmon Pharmaceuticals LLC |
| Substance Name | AMPHOTERICIN B |
| Strength Number | 100 |
| Strength Unit | mg/100mg |
| Pharmaceutical Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] |
